Correlation Between Biofil Chemicals and R S

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biofil Chemicals and R S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biofil Chemicals and R S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biofil Chemicals Pharmaceuticals and R S Software, you can compare the effects of market volatilities on Biofil Chemicals and R S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biofil Chemicals with a short position of R S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biofil Chemicals and R S.

Diversification Opportunities for Biofil Chemicals and R S

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Biofil and RSSOFTWARE is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Biofil Chemicals Pharmaceutica and R S Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on R S Software and Biofil Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biofil Chemicals Pharmaceuticals are associated (or correlated) with R S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of R S Software has no effect on the direction of Biofil Chemicals i.e., Biofil Chemicals and R S go up and down completely randomly.

Pair Corralation between Biofil Chemicals and R S

Assuming the 90 days trading horizon Biofil Chemicals is expected to generate 6.15 times less return on investment than R S. But when comparing it to its historical volatility, Biofil Chemicals Pharmaceuticals is 1.07 times less risky than R S. It trades about 0.02 of its potential returns per unit of risk. R S Software is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  2,647  in R S Software on September 3, 2024 and sell it today you would earn a total of  18,721  from holding R S Software or generate 707.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Biofil Chemicals Pharmaceutica  vs.  R S Software

 Performance 
       Timeline  
Biofil Chemicals Pha 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Biofil Chemicals Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical indicators, Biofil Chemicals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.
R S Software 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days R S Software has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Biofil Chemicals and R S Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biofil Chemicals and R S

The main advantage of trading using opposite Biofil Chemicals and R S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biofil Chemicals position performs unexpectedly, R S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in R S will offset losses from the drop in R S's long position.
The idea behind Biofil Chemicals Pharmaceuticals and R S Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Directory
Find actively traded commodities issued by global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments